SillaJen Collaboration

About Qureator

Qureator is a private, pre-revenue biotech company pioneering a novel drug discovery platform that integrates advanced human-relevant disease models with artificial intelligence. The company's core technology consists of CurioChips, a high-throughput microphysiological system (MPS) that recreates complex human biology, and QuriCore AI, a multimodal neural network for predictive data analysis. This integrated approach is designed to identify new drug targets, synergistic combinations, and predict clinical outcomes, with a current focus on metastatic cancer and immunotherapy. A significant milestone includes an FDA IND approval based on its human-relevant data, signaling validation of its platform's potential to reduce reliance on animal models.

Therapeutic Areas

Other Not Specified Drugs